A bibliometric and visualized analysis of interventional treatment for intracranial atherosclerotic stenosis (from

Kai Du1, Jieqin Gong1, Jizhen Li1

  • 1Department of Neurology, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou, 215028, China.

Neurosurgical Review
|March 22, 2025
PubMed

Insights

Interventional therapies for intracranial atherosclerotic stenosis show growing research, particularly from the US and China. Future research should focus on personalized treatments for stroke prevention.

Area of Science:

  • Neurology
  • Interventional Cardiology
  • Bibliometrics

Background:

  • Intracranial atherosclerotic stenosis (ICAS) is a major cause of ischemic stroke.
  • Recurrence risk remains high despite medical management.
  • Interventional strategies are increasingly researched for ICAS.

Purpose of the Study:

  • To evaluate the current landscape of interventional therapies for ICAS.
  • To identify future research directions in this field.
  • To provide insights and recommendations for ICAS interventional research.

Main Methods:

  • Bibliometric analysis of publications from 2004-2023.
  • Data sourced from the Web of Science Core Collection.
  • Analysis tools included VOSviewer and CiteSpace.

Main Results:

  • 3,384 articles were included in the analysis.
  • Publication volume has increased significantly over two decades.
  • The United States leads publications; China shows recent growth.
  • Capital Medical University, Derdeyn C.P., Levy E.I., and Journal of Neurointerventional Surgery are key contributors.

Conclusions:

  • Interventional treatments for ICAS have substantial future potential.
  • Personalized and precise therapeutic strategies are needed.
  • Rigorous multicenter research is crucial for advancing ICAS interventions.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
53